Cargando…
The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression
PURPOSE: To evaluate progression rates with dorzolamide compared with other hypotensive agents in primary open-angle glaucoma. METHODS: Patients who were treated over 5 years with dorzolamide versus other hypotensive agents were reviewed. The groups were matched by intraocular pressure, cardiovascul...
Autores principales: | Diafas, Savvas, G Day, Douglas, Stewart, Jeanette A, Stewart, William C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376072/ https://www.ncbi.nlm.nih.gov/pubmed/18472997 |
Ejemplares similares
-
Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Inoue, Kenji, et al.
Publicado: (2011) -
Stereoselective
Solvolysis in the Synthesis of Dorzolamide
Intermediates
por: Martinelli, Andrea, et al.
Publicado: (2023) -
Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film
por: Sedlak, Lech, et al.
Publicado: (2021) -
Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015) -
Allergic contact dermatitis to dorzolamide and benzalkonium chloride
por: Orsini, Diego, et al.
Publicado: (2018)